Almatica Pharma
Focus: Almatica Pharma is a newly established (2024) public pharmaceutical company focused on small-molecule therapeutics across neurology, infectious diseases, cardiovascular, and psychiatry. The company operates primarily as a custodian of legacy branded products with significant revenue concentration in mature assets.
Profile data last refreshed 11h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
9-1 this month
Stable — net -1 jobs in 30d
4 added, 5 removed. Backfill posture.
Should You Work at Almatica Pharma?
AI assessmentA stable, short-term commercial role suitable for operations/regulatory/finance professionals, but unsuitable for scientists or innovators seeking pipeline exposure or long-term career growth in a declining-revenue business.
Why Work Here
- Established public company with proven commercial infrastructure across multiple therapeutic areas (neurology, psychiatry, cardiovascular, infectious disease).
Data completeness
5/9 — Partial
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
1 imminent
VENLAFAXINE BESYLATE
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$23M Part DDeclining
LOE Approaching
Flagship product accounting for 53% of company revenue; exclusive formulation advantage eroding as generic gabapentin market matures.
Help build intelligence for Almatica Pharma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.